A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Adalimumab
Related studies linked through entity extraction aliases.
Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
- Status
- COMPLETED
- Phase
- N/A
Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate
- Status
- TERMINATED
- Phase
- PHASE2
Treatments Against RA and Effect on FDG-PET/CT
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)
- Status
- COMPLETED
- Phase
- PHASE2
Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
- Status
- COMPLETED
- Phase
- N/A
Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects
- Status
- COMPLETED
- Phase
- PHASE4
Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
- Status
- COMPLETED
- Phase
- PHASE3
Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients
- Status
- TERMINATED
- Phase
- PHASE3
Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease
- Status
- COMPLETED
- Phase
- PHASE4